✦ LIBER ✦

529 Cost-effectiveness and budget impact of the 70-gene signature for node-negative breast cancer

✍ Scribed by V.P. Retel; M.A. Joore; M. Knauer; S.C. Linn; M. Hauptmann; W.H. van Harten

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A new independent validation of the 70-g

✍ J.M. Bueno de Mesquita; Keijzer; S.C. Linn; A.A.M. Hart; C. Van Krimpen; C. Meij 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 134 KB

Validation and Clinical Utility of a 70-

✍ Hayes, D.F. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Cost-effectiveness of the 70-gene signat

✍ Valesca P. Retèl; Manuela A. Joore; Michael Knauer; Sabine C. Linn; Michael Haup 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 372 KB

5167 French cost effectiveness study of

✍ Zarca, D.; Stork-Sloots, L.; de Snoo, F.; Brink, G.; Dervaux, Y.; Boubli, L. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Cost-utility of the 21-gene recurrence s

✍ Nathan W. D. Lamond, Chris Skedgel, Daniel Rayson, Lynn Lethbridge, Tallal Youni 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 462 KB

207 70-Gene Signature Prospectively Pred

✍ S.C. Linn; C.A. Drukker; V.P. Retel; J.M. Bueno-de-Mesquita; W.H. van Harten; H. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 58 KB